ID

13757

Description

Study of Sapacitabine in Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01211457

Link

https://clinicaltrials.gov/show/NCT01211457

Keywords

Versions (1)
  1. 3/3/16 3/3/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

March 3, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC-ND 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Myeloid Leukemia NCT01211457

English

Eligibility Acute Myeloid Leukemia NCT01211457

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed aml based on who classification
Description

de novo aml

Data type

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1515568
age 70 years or older for whom the treatment of choice is low-intensity therapy by investigator assessment or who has refused intensive induction therapy recommended by investigator
Description

age and chemotherapy regimen

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0392920
ecog performance status 0-2
Description

ECOG

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate renal function
Description

renal function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
adequate liver function
Description

liver function

Data type

boolean

Alias
UMLS CUI [1]
C0232741
able to swallow capsules
Description

capsules

Data type

boolean

Alias
UMLS CUI [1]
C0006935
ability to understand and willingness to sign the informed consent form
Description

informed consent form

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
aml is of the sub-type of acute promyelocytic leukemia or extramedullary myeloid tumor without bone marrow involvement
Description

APL or extramedullary myeloid tumor

Data type

boolean

Alias
UMLS CUI [1]
C0023487
UMLS CUI [2,1]
C2939461
UMLS CUI [2,2]
C1517060
having received any systemic anti-cancer therapy for aml or received treatment with hypomethylating agents or cytotoxic chemotherapy for the preceding mds or mpd
Description

prior therapy for aml

Data type

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1514463
UMLS CUI [2,1]
C2613367
UMLS CUI [2,2]
C0013227
UMLS CUI [3]
C0392920
UMLS CUI [4]
C3463824
known central nervous system (cns) involvement by leukemia
Description

cns leukemia

Data type

boolean

Alias
UMLS CUI [1]
C1332884
uncontrolled intercurrent illness including
Description

comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
known hypersensitivity to decitabine
Description

hypersensitivity to decitabine

Data type

boolean

Alias
UMLS CUI [1,1]
C0049065
UMLS CUI [1,2]
C0020517
known to be hiv-positive
Description

hiv

Data type

boolean

Alias
UMLS CUI [1]
C0019682
Back to the top of the page

Similar models

Eligibility Acute Myeloid Leukemia NCT01211457

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
de novo aml
Item
newly diagnosed aml based on who classification
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
age and chemotherapy regimen
Item
age 70 years or older for whom the treatment of choice is low-intensity therapy by investigator assessment or who has refused intensive induction therapy recommended by investigator
boolean
C0001779 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
ECOG
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
renal function
Item
adequate renal function
boolean
C0232804 (UMLS CUI [1])
liver function
Item
adequate liver function
boolean
C0232741 (UMLS CUI [1])
capsules
Item
able to swallow capsules
boolean
C0006935 (UMLS CUI [1])
informed consent form
Item
ability to understand and willingness to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
APL or extramedullary myeloid tumor
Item
aml is of the sub-type of acute promyelocytic leukemia or extramedullary myeloid tumor without bone marrow involvement
boolean
C0023487 (UMLS CUI [1])
C2939461 (UMLS CUI [2,1])
C1517060 (UMLS CUI [2,2])
prior therapy for aml
Item
having received any systemic anti-cancer therapy for aml or received treatment with hypomethylating agents or cytotoxic chemotherapy for the preceding mds or mpd
boolean
C0023467 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2613367 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C3463824 (UMLS CUI [4])
cns leukemia
Item
known central nervous system (cns) involvement by leukemia
boolean
C1332884 (UMLS CUI [1])
comorbidity
Item
uncontrolled intercurrent illness including
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to decitabine
Item
known hypersensitivity to decitabine
boolean
C0049065 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
hiv
Item
known to be hiv-positive
boolean
C0019682 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial